title: Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.
abstract: OBJECTIVE
  To report a case of posterior uveitis with retinal neovascularization in a patient with Behet disease treated with infliximab.
  
  
  METHODS
  A 50-year-old man with a history of recurrent relapses of ocular inflammation despite immunosuppressive therapy developed retinal neovascularization near the optic disk. The patient was treated with infliximab and followed up for 12 months.
  
  
  RESULTS
  Retinal neovascularization regressed 8 months after the first antitumor necrosis factor (TNF) treatment and with six infusions of infliximab. The ocular inflammation resolved almost completely.
  
  
  CONCLUSIONS
  The result suggests that anti-TNF therapy may be effective in the treatment of retinal neovascularization caused by panuveitis in Behet disease. (Eur J Ophthalmol 2004; 14: #-8).
authors.affiliation: Eye Clinic, Department of Oto-Neuro-Ophthalmological Surgical Sciences, University of Firenze, Firen.
authors.forename: F
authors.initials: F
authors.lastname: Giansanti
authors.forename: M L
authors.initials: ML
authors.lastname: Barbera
authors.forename: L
authors.initials: L
authors.lastname: Virgili
authors.forename: B
authors.initials: B
authors.lastname: Pieri
authors.forename: L
authors.initials: L
authors.lastname: Emmi
authors.forename: U
authors.initials: U
authors.lastname: Menchini